CytoMed Therapeutics Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GDTC | INAB | SNTI | TCRX | CYP.AX | IMMP | |
|---|---|---|---|---|---|---|
| Market cap | 10.61M | 9.18M | 6.79M | 14.23M | 4.38M | 21.74M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -5.9 | -1.0 | -0.2 | -0.4 | -0.2 | -0.9 |
| Price/book | 2.7 | 0.5 | -1.6 | 0.2 | -6.5 | 0.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −56.87% | −41.72% | −90.82% | −83.35% | −94.47% | −91.38% |
| Today | −2.31% | −2.02% | −0.73% | +11.11% | 0.00% | −1.50% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All GDTC news ›CytoMed Therapeutics chairman reports 25.17% stake
The chairman bought 29,250 shares in CytoMed Therapeutics (NASDAQ: GDTC) and reported his stake. Stock Titan - [SCHEDULE 13D/A] CytoMed Therapeutics Ltd Amended Major Shareholder Report CytoMed Therapeutics chairman reports 25.17% stake…
CytoMed Therapeutics chairman buys 62,000 shares
CytoMed Therapeutics (NASDAQ: GDTC) chairman buys shares, reports a 24.92% stake. Stock Titan - [SCHEDULE 13D/A] CytoMed Therapeutics Ltd Amended Major Shareholder Report CytoMed Therapeutics chairman buys 62,000 shares His reported…
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
The notice leaves current listing, trading and business operations unaffected, while compliance must be restored within the grace period. CytoMed Therapeutics (NASDAQ: GDTC) received a Nasdaq notice on October 6, 2026, identifying a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net3
- globenewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.